ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

Qing, Xin; Yuan, Chunlei*; Wang, Ke*南方医科大学; 四川大学
Breast Cancer2023-5DOI: 10.1007/s12282-023-01435-8
6阅读
引用收藏
分享

摘要

BackgroundProteomics profiles have enabled a systematic insight into the prognosis of cancer. This study aimed to establish a valuable protein-based risk signature to assess the prognosis and immune status in patients with breast cancer (BC).MethodsProtein expression profile, RNA expression data, and clinical information were acquired from The Cancer Genome Atlas (TCGA). The whole cohort was randomly split into two cohorts, one for establishing the risk signature and the other for testing. Univariate Cox analysis and Least absolute shrinkage and selection operator (LASSO) Cox regression were utilized to construct the protein-based risk signature. All cohorts were divided into high- and low-risk groups, which were applied to investigate the clinical relevance, tumor microenvironment, and therapeutic response.ResultsThe prognostic proteomics signature was established based on prognostic proteins, thus categorizing patients into low-risk and high-risk groups with different prognoses. A predictive nomogram was also developed to predict 1, 3, and 5-year survival possibility for BC patients, and the calibration curves confirmed the predictive significance of this signature. Afterward, the low-risk group displayed higher immune activities, immune checkpoint expression, and immunotherapeutic response. Moreover, GSEA analysis indicated that immune-associated pathways were rich in the low-risk group. Additionally, this prognostic signature demonstrated potential predict significance for chemotherapeutic agents.ConclusionThis study established an effective prognostic proteomics signature with reliable predictive performance for survival, immune activity, and drug sensitivity. It might provide a novel perspective into the protein function in BC, and guide the individual treatment strategies for BC patients.

学科与关键词

关键词
Breast cancerProteomicsPrognostic signatureTumor-infiltrating immune cellsTreatment
相关
加载中…
  • Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis
    Yu, Yunlin; Dong, Linhuan; Dong, Changjun; Zhang, Xianlin*International Journal of Genomics, 2023, 2023: 1738750.
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
  • Immune-related Gene-based Prognostic Signature for the Risk Stratifica-tion Analysis of Breast Cancer
    Su, Dongqing; Lu, Qianzi; Pan, Yi; Yu, Yao; Wang, Shiyuan; Zuo, Yongchun*; Yang, Lei*Current Bioinformatics, 2022, 17(2): 196-205.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Breast Cancer
发表日期
2023-05
卷期
第 30 卷, 第 3 期
页码
424-435
DOI
10.1007/s12282-023-01435-8
语言
ENGLISH
成果收录
SCIE

作者

  • Q

    Qing, Xin (第一作者)

    sichuan univ · southern med univ

  • Y

    Yuan, Chunlei (通讯)

    southern med univ

查看全部 3 位作者收起作者
  • W

    Wang, Ke (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417